AzTrials
AzTrials

Subacromial Pain SyndromeNCT03317808

Exercise for Subacromial Pain Syndrome

A study testing Different exercise in people with Subacromial Pain Syndrome, run by Oslo University Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the effect of Heavy Slow Resistance exercise (HSR) exercise in comparison with traditional supervised exercise as treatment for patients with subacromial shoulder pain. Read more about this study

Who is it for?
Ages 25 to 70 years
Conditions the study is for
Subacromial Pain Syndrome
What is being tested?
Different exercise
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
22 participants
Where
1 siteNorway
Study dates
16 Oct 2017to 13 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Shoulder pain > Three months
  • Subacromial pain
  • Dysfunction or pain during abduction
  • Pain during isometric strength test of abduction or external rotation of the shoulder.
  • Positive Hawkins test
  • Normal passive range of movement in the glenohumeral joint

Who cannot join

  • Surgery of the affected shoulder
  • Patients that are not considered suitable to complete the treatment, or able to answer a Norwegian questionnaire
  • Shoulder dislocation or shoulder instability
  • Clinical sign of cervical nerve root affection
  • Rheumatoid arthritis
  • Clinical sign of full rupture of the rotator cuff.
  • Pregnancy
  • Cortisone injection past six weeks

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Ullevål Sykehus

    Oslo, 0450 Oslo

Other trials in Norway

About this study

Official title: Heavy Slow Resistance Exercise for Subacromial Pain Syndrome

This study evaluates the effect of Heavy Slow Resistance exercise (HSR) exercise in comparison with traditional supervised exercise as treatment for patients with subacromial shoulder pain. The purpose is to evaluate if HSR is feasible fir these patients, and compare its effect to traditional exercise at pain and function of the shoulder. One half will complete the heavy slow resistance exercise, the other will complete the conventional exercise.

Being tested
Different exercise

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Different exerciseDiagnostic test

    Evaluating the difference between Heavy slow resistance and traditional exercise, based on the SPADI score.

Study groups in NCT03317808
Study groupRoleWhat they receive
Heavy slow resistance exerciseActive comparatorNot described
Receives: Diagnostic Test: Different exercise
Traditional supervised exercisePlacebo comparatorNot described
Receives: Diagnostic Test: Different exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline SPADI score at 12- and 24 weeks.

    The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire that consists of two dimensions, one for pain and the other for functional activities. The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use. Both dimensions account for 50% of the overall score, and scores from 0 to 100.

    Measured: Measured three times. Firstly at the baseline. Secondly at the 12-week follow up (after finished intervention). Lastly at the 24-week follow up.

Secondary outcomes (6)
  1. Change from Baseline "Pain in rest last week" score at 12- and 24 weeks.

    11 point Likert-type scale, 0 =no pain, 10 = worst possible pain. Measured by marking a clean visual analogue scale, and later transferred to a score.

    Measured: Measured three times. Firstly at the baseline. Secondly at the 12-week follow up (after finished intervention). Lastly at the 24-week follow up.

  2. Change from Baseline "Pain in activity last week" score at 12- and 24 weeks.

    11 point Likert-type scale, 0 =no pain, 10 = worst possible pain. Measured by marking a clean visual analogue scale, and later transferred to a score.

    Measured: Measured three times. Firstly at the baseline. Secondly at the 12-week follow up (after finished intervention). Lastly at the 24-week follow up.

  3. Change From Baseline "The ability to carry a 5kg carry bag" score at 12- and 24 weeks.

    11 point Likert-type scale, 0 = no problem, 10 = impossible. Measured by marking a clean visual analogue scale, and later transferred to a score.

    Measured: Measured three times. Firstly at the baseline. Secondly at the 12-week follow up (after finished intervention). Lastly at the 24-week follow up.

  4. Change from Baseline DASH score at 12- and 24 weeks.

    DISABILITIES OF THE ARM, SHOULDER AND HAND (DASH) is a 30 points questionnaire about the disability of the shoulder. Answers from 0 to 5; 0 0 No problem completing the activity, 5 = Impossible to complete the activity. Total score is calculated by a summary of the scores, subtracted by 30 and divided by 1.2.

    Measured: Measured three times. Firstly at the baseline. Secondly at the 12-week follow up (after finished intervention). Lastly at the 24-week follow up.

  5. Change from Baseline Active range of motion of the shoulder at 12- and 24 weeks.

    A total score the flection, abduction and external rotation of the shoulder. Measured by goniometer.

    Measured: Measured three times. Firstly at the baseline. Secondly at the 12-week follow up (after finished intervention). Lastly at the 24-week follow up.

  6. Change from "The ability to take something down from a high shelf" score at 12- and 24 weeks.

    11 point Likert-type scale, 0 = no problem, 10 = impossible. Measured by marking a clean visual analogue scale, and later transferred to a score.

    Measured: Measured three times. Firstly at the baseline. Secondly at the 12-week follow up (after finished intervention). Lastly at the 24-week follow up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Oct 2017
  2. Study start16 Oct 2017
  3. Primary completion13 Dec 2018
  4. Study completion13 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03317808
Sponsor's protocol ID
2017/1277
Status last verified
Jan 2019
First submitted
15 Oct 2017
Last updated
25 Jan 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Different exercise in people with Subacromial Pain Syndrome, run by Oslo University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline SPADI score at 12- and 24 weeks. (time frame: Measured three times. Firstly at the baseline. Secondly at the 12-week follow up (after finished intervention). Lastly at the 24-week follow up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in